Table 3.
Source of Exosomes | Component | Mechanism | Function | Experiment Type | Reference |
---|---|---|---|---|---|
Macrophages | Modulating microglial polarity | Anti-inflammation | In vitro and in vivo | [96] | |
Macrophages | Drp1-Fis1 interaction | Reduce mitochondrial damage in astrocytes | In vitro and in vivo | [97] | |
Macrophage | Targets neuronal cells and microglia | Reduce inflammation response | In vivo | [98] | |
Macrophages | Downregulating ROS | Protect BBB and antagonize neuronal apoptosis | In vitro and in vivo | [99] | |
M2 macrophages | Activate Nrf2/HO-1 signaling pathway | Inhibit ROS, protect HT22 neurons | In vitro | [100] | |
Dental pulp stem cell | Inhibit HMGB1/TLR4/MyD88/NF-κB pathway | Anti-inflammation | In vitro and in vivo | [102] | |
USCs | MiR-26a/HDAC6 axis | Promote neurogenesis | In vitro and in vivo | [103] | |
USCs | miR-21-5p | EPha4/TEK axis | Promote neurogenesis | In vitro and in vivo | [104] |
Olfactory mucosa MSCs | miR-612-TP53-HIF-1α-VEGF axis | Promote the formation of HBMECs | In vitro and in vivo | [105] | |
HUECs | miR-1290 | Cav-1 upregulates intake of HUECs-EVs | Attenuates apoptosis | In vitro and in vivo | [101] |
Intestinal epithelium cells | miRNA | Promote apoptosis, necroptosis, and/or pyroptosis of cortical neurons | In vitro | [106] | |
MC-ELNs | AKT/GSK3β signaling pathway | Protect BBB and anti-apoptosis | In vivo | [107] | |
MCEs | Inhibit platelet activation, aggregation, adhesion, and HCT116 cells migration | In vitro and in vivo | [108] |
USCs, urine-derived stem cells; MSCs, mesenchymal stem cells; HUECs, human umbilical endothelial cell; MC, momordica charantia; ELNs, exosome-like nanoparticles; MCEs, MC-exosomes.